Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
MYSE · 10-Q filed August 14, 2026

MYSE earnings analysis

What we found in MYSE's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

The filing excerpt does not provide income-statement, balance-sheet, cash-flow, or segment results, so quarterly financial trends cannot be assessed from the supplied text. The principal disclosure is that controls were ineffective as of June 30, 2026, with 3 material weaknesses related to staffing, management review, and system controls. The company is pursuing remediation, while issuing 20,000 shares valued at $59,800 and 102,101 restricted shares valued at $200,000 for services. No quantitative guidance was provided, and management reported no material changes to the risk factors from the December 31, 2025 Annual Report.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Remediation plan disclosed
Management identified 3 material weaknesses in internal control over financial reporting: insufficient segregation of duties, inadequate management review, and inadequate system and manual controls. Remediation may include hiring additional accounting and finance personnel and establishing disbursement review and approval processes.
Equity issued for services
The company issued 20,000 common shares valued at $59,800, or $2.99 per share, on April 23, 2026, and 102,101 restricted common shares valued at $200,000 on June 11, 2026.
No share repurchases
The company reported no common-stock repurchases during the quarterly period ended June 30, 2026.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Ineffective financial controls
Management concluded that disclosure controls and procedures were not effective as of June 30, 2026, citing limited resources and a limited number of employees. The 3 identified material weaknesses remain outstanding until controls operate effectively for a sufficient period and are validated through testing.
Service-related equity dilution
The issuance of 20,000 shares for $59,800 and 102,101 restricted shares for $200,000 creates potential equity dilution while the company relies on equity compensation for consulting and investor-relations services.
Litigation and unknown risks
The filing states that adverse litigation outcomes could harm the business, financial condition, or operating results, although the company is currently unaware of proceedings or claims expected to have a material adverse effect. The company also notes that risks not currently known or deemed immaterial could materially adversely affect results.
Guidance

What they said about what is next.

The filing provides no quantitative revenue or EPS outlook. Management states remediation of internal-control weaknesses is ongoing; the risk-factor section reports no material changes from the December 31, 2025 Annual Report.

How we read the filing overall

The filing reads worse than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · May 15, 2026
Myseum.AI reported a revenue of $73 million for Q1 2026, a decline from $83 million in Q1 2025, contributing to a net loss increase of 76.7% year-over-year. The company is investing heavily in marketing, resulting in a…
10-K · March 30, 2026
Myseum (formerly DatChat) is an early-stage privacy-focused social/media technology company that launched Myseum in March 2025 and Picture Party by Myseum in December 2025. The company holds 20 issued U.S. patents (as…
10-Q · November 13, 2025
Myseum reported Q3 net revenue of $328, up from $62 in Q3 2024 (+$266), while loss from operations was $1,280,601 and GAAP net loss was $1,231,481. EPS improved to $(0.28) from $(0.42) year-over-year, but the company…
10-Q · August 14, 2025
Q2 2025 results show continuing operating losses and sharply lower revenue: net revenues were $78 for the quarter and diluted EPS was $(0.29). The company raised equity (net proceeds $4,532,000) and increased short-term…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing MYSE makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever